Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testing

28 May 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Lymphoma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34052294
DOI: 10.1016/j.humpath.2021.05.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testingPMID 34052294Read ↗

Detecting mismatch repair deficiency in solid neoplasms: immunohistochemistry, microsatellite instability, or both?Semantic proximity Read ↗

Evaluating Multiple Next-Generation Sequencing–Derived Tumor Features to Accurately Predict DNA Mismatch Repair StatusSemantic proximity Read ↗

Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory MethodsSemantic proximity Read ↗

Mismatch Repair Status Characterization in Oncologic Pathology: Taking Stock of the Real-World PossibilitiesSemantic proximity Read ↗

Mismatch repair deficiency: The what, how and why it is importantSemantic proximity Read ↗

Utilizing microsatellite instability and immunohistochemistry to clinically interpret a novel germline mismatch repair mutation of uncertain significanceSemantic proximity Read ↗

Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists GuidelineSemantic proximity Read ↗

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors.Semantic proximity Read ↗

DNA Damage and Repair Biomarkers of Immunotherapy ResponseSemantic proximity Read ↗

Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer seriesSemantic proximity Read ↗

The role of DNA mismatch repair in immunotherapy of human cancer.Semantic proximity Read ↗

Benchmarking mismatch repair testing for patients with cancer receiving immunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.